Katherine J Walsh MD
Associate Professor of Clinical Internal Medicine and Clerkship Director for the third year medical student Inpatient IM Clerkship, Ohio State University College of Medicine
Join to View Full Profile
3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000
Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
University of FloridaResidency, Internal Medicine, 2004 - 2007- University of Florida College of MedicineClass of 2004
Certifications & Licensure
TN State Medical License 2021 - 2027
OH State Medical License 2011 - 2021
NC State Medical License 2008 - 2012
GA State Medical License 2007 - 2011
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Sep 17
Publications & Presentations
PubMed
- Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase.Joseph F Mort, David Brighton, Benjamin Mautner, Eric Pierce, Farid Ghamsari
Blood Vessels, Thrombosis & Hemostasis. 2025-08-01 - Teaching Communication Skills and Developing Comfort With Difficult Conversations: A Combined Palliative Care-Oncology Simulation Session for Hematology/Oncology Fellows.Megan M Dupuis, Katherine J Walsh, Rajiv Agarwal
JCO Oncology Practice. 2025-07-29 - 1 citationsEvaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.Joseph F Mort, David Brighton, Samantha DiBenedetto, Leah Wells, Stephen M Clark
European Journal of Haematology. 2025-03-01
Abstracts/Posters
- Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration t...Katherine J. Walsh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Te...Katherine J. Walsh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best...Katherine J. Walsh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Plenary Highlights Across Tumor Types Reflect Advances in Research, Improvements in Care, and Changes in PracticeJuly 25th, 2025- Rusfertide Reduces Need for Phlebotomy in Polycythemia VeraJune 2nd, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
